TY - JOUR
T1 - Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology
T2 - An undying implication of epigenetic and autophagy modulation
AU - Kakoty, Violina
AU - Kc, Sarathlal
AU - Kumari, Shobha
AU - Yang, Chih Hao
AU - Dubey, Sunil Kumar
AU - Sahebkar, Amirhossein
AU - Kesharwani, Prashant
AU - Taliyan, Rajeev
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature Switzerland AG.
PY - 2023
Y1 - 2023
N2 - In metabolic syndrome, dysregulated signalling activity of the insulin receptor pathway in the brain due to persistent insulin resistance (IR) condition in the periphery may lead to brain IR (BIR) development. BIR causes an upsurge in the activity of glycogen synthase kinase-3 beta, increased amyloid beta (Aβ) accumulation, hyperphosphorylation of tau, aggravated formation of Aβ oligomers and simultaneously neurofibrillary tangle formation, all of which are believed to be direct contributors in Alzheimer’s Disease (AD) pathology. Likewise, for Parkinson’s Disease (PD), BIR is associated with alpha-synuclein alterations, dopamine loss in brain areas which ultimately succumbs towards the appearance of classical motor symptoms corresponding to the typical PD phenotype. Modulation of the autophagy process for clearing misfolded proteins and alteration in histone proteins to alleviate disease progression in BIR-linked AD and PD have recently evolved as a research hotspot, as the majority of the autophagy-related proteins are believed to be regulated by histone posttranslational modifications. Hence, this review will provide a timely update on the possible mechanism(s) converging towards BIR induce AD and PD. Further, emphasis on the potential epigenetic regulation of autophagy that can be effectively targeted for devising a complete therapeutic cure for BIR-induced AD and PD will also be reviewed. Graphical abstract: [Figure not available: see fulltext.]
AB - In metabolic syndrome, dysregulated signalling activity of the insulin receptor pathway in the brain due to persistent insulin resistance (IR) condition in the periphery may lead to brain IR (BIR) development. BIR causes an upsurge in the activity of glycogen synthase kinase-3 beta, increased amyloid beta (Aβ) accumulation, hyperphosphorylation of tau, aggravated formation of Aβ oligomers and simultaneously neurofibrillary tangle formation, all of which are believed to be direct contributors in Alzheimer’s Disease (AD) pathology. Likewise, for Parkinson’s Disease (PD), BIR is associated with alpha-synuclein alterations, dopamine loss in brain areas which ultimately succumbs towards the appearance of classical motor symptoms corresponding to the typical PD phenotype. Modulation of the autophagy process for clearing misfolded proteins and alteration in histone proteins to alleviate disease progression in BIR-linked AD and PD have recently evolved as a research hotspot, as the majority of the autophagy-related proteins are believed to be regulated by histone posttranslational modifications. Hence, this review will provide a timely update on the possible mechanism(s) converging towards BIR induce AD and PD. Further, emphasis on the potential epigenetic regulation of autophagy that can be effectively targeted for devising a complete therapeutic cure for BIR-induced AD and PD will also be reviewed. Graphical abstract: [Figure not available: see fulltext.]
KW - Alzheimer’s disease
KW - Autophagy
KW - Brain insulin resistance
KW - Epigenetics
KW - Parkinson’s disease
UR - http://www.scopus.com/inward/record.url?scp=85150651964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150651964&partnerID=8YFLogxK
U2 - 10.1007/s10787-023-01187-z
DO - 10.1007/s10787-023-01187-z
M3 - Review article
AN - SCOPUS:85150651964
SN - 0925-4692
VL - 31
SP - 699
EP - 716
JO - Inflammopharmacology
JF - Inflammopharmacology
IS - 2
ER -